The lab welcomes Blaire Bacher to the lab. She is replacing Mike Grupe as lab manager.
Welcome, Blaire Bacher!

The lab welcomes Blaire Bacher to the lab. She is replacing Mike Grupe as lab manager.
Dustin Baldridge and Emily Orr attended the American Society for Human Genetics Annual Meeting in Denver, CO in November 2024. Dustin was excited to present our lab’s hard work to generate a heatmap for the Deep Mutational Scan of GLI2! Emily also represented our lab’s work on the genetics of transcription factors involved in substance […]
Members of Dustin’s lab (Jiye Yi, Mike Grupe, Caitlyn Chitwood and Emily Orr) attended the Staff Appreciation lunch.
Today we officially said goodbye and thanks to Jaeden Flury, who has spent the last year in our lab. We made an outing to a nearby TopGolf facility. Jaeden has made valuable contributions to the progress of our lab. She will be back at Wash U, beginning in August, to begin her PhD work. After doing […]
Emily Orr attended the National Institute of Drug Abuse (NIDA) Genetics and Epigenetics Cross-Cutting Research Team Meeting at NIH headquarters in Bethesda MD, May 2024. She presented her poster, “Applying high Throughput deep mutational scanning to study transcription factors implicated in the biology of substance use disorders”. The meeting featured over 200 researchers covering GWAS, […]
Dustin and Emily attended this year’s Pediatrics Department Research Retreat along with 300 other pediatrics researchers and staff. Emily presented her poster titled “Development of transcription factor reporter assays to functionally test disease-associated variants via high throughput deep mutational scanning (DMS).” DMS is increasingly becoming an area of interest in the translational sciences, including being […]
June 21, 2024 update: Jaeden will be staying here at Wash U for her PhD!
Baldridge’s award will help fund the use of cutting-edge, high-throughput techniques to study thousands of genetic variants associated with substance use disorders and determine which variants have the greatest molecular consequences. The work ultimately may uncover biological targets for future treatments.